Portfolio Update

BLACKROCK SMALLER COMPANIES TRUST plc All information is at 31 January 2009 and unaudited. Performance at month end is calculated on a capital only basis One Three One Three Five Month Months Year Years Years Net asset value -1.0% -6.7% -39.3% -33.8% 1.7% Share price -0.3% -3.2% -41.5% -39.4% 4.2% HGSC ex Inv Trust + AIM* -0.5% -5.2% -45.5% -49.5% -35.8% Sources: BlackRock and Datastream *With effect from 1 September 2007 the Hoare Govett Smaller Companies plus AIM (ex Investment Companies) Index replaced the FTSE SmallCap Index (ex Investment Companies) as the Company's benchmark. For three year and five year periods the above index has been blended to reflect this. At month end Net asset value Capital only (debt at par value): 230.29p Net asset value Capital only (debt at fair value): 224.79p Net asset value incl Income (debt at par value): 235.02p** Net asset value incl Income (debt at fair value): 229.52p** Share price: 181.00p Discount to Capital only NAV (debt at par value): 21.4% Discount to Capital only NAV (debt at fair value): 19.5% Net yield: 3.43% Total assets: £128.8m^ Gearing incl. income: 13.6% Ordinary shares in issue: 48,494,792^^ **includes net revenue of 4.73p. ^includes current year revenue. ^^excludes 1,498,731 shares held in treasury. Ten Largest Sector Weightings % of Total Assets Support Services 15.6 Software & Computer Services 10.9 Financial Services 10.7 Aerospace & Defence 9.2 Industrial Engineering 6.5 Oil & Gas Producers 5.8 Health Care Equipment & Services 5.1 Pharmaceuticals & Biotechnology 4.8 Electronic & Electrical Equipment 3.7 Nonlife Insurance 3.3 ---- Total 75.9 ==== Ten Largest Equity Investments (in alphabetical order) Company Aveva Group Brewin Dolphin Holdings Chemring Group Connaught Dechra Pharmaceuticals Fidessa Group London Capital Group Holding Mouchel Group Rathbone Brothers Ultra Electronics Holdings Commenting on the markets, Mike Prentis, representing the Investment Manager noted: January was a calmer month with the NAV (on a capital only basis) falling by 1.0%; the benchmark declined by 0.5%. The FTSE 100 Index fell by 6.4% during the month. The main contributors to relative outperformance during the month were holdings in Dechra Pharmaceuticals, Chemring, Fidessa and Emerald Energy. Dechra released a confident pre-close update; on a like for like basis its sales in the six months to 31 December 2008 were up 9.5% on the prior comparable period. High margin pharmaceutical sales are increasing strongly. Chemring, which supplies military decoys and explosives, produced excellent full year results with earnings up 43%; the order book gives good visibility of 2009 revenues. Fidessa is due to report its full year results in mid February. We believe the shares are excellent value at 1 times EV/sales for a world leading software company with 75% of its revenues recurring and a cash rich balance sheet, albeit selling to a challenged customer base. Emerald Energy continued to have drilling success in Syria. Its oil production has grown strongly and the group is cash rich. On the negative side, the holdings which detracted most from relative performance were BATM Advanced Communications and Rathbone Brothers. BATM shares were weak because the market fears the telecom capex will fall and this will curb BATM's growth. BATM's products are advanced and sell into higher growth areas of the telecoms market. Despite this, some destocking is inevitable followed by lower growth. Much of this should be allowed for in recently downgraded current year forecasts. Stripping out BATM's considerable cash resources, it trades on only 3 times current year downgraded earnings. Rathbones shares had been amongst our strongest performers in prior months. New holdings in the month were Burberry, Charter, Lancashire and Eaga. We sold the holding in Hiscox. The purchases of shares in international fashion brand Burberry and steel related Charter reflect our desire to increase our exposure to good quality, well funded, more cyclical companies. Both have performed well since purchase. We switched our holding in insurer Hiscox, which had performed well, into cheaper Lancashire. Eaga provides efficient energy solutions to the less well off; it has good long term revenue predictability. We remain defensively positioned with overweight positions in defence, software, healthcare and engineering companies. We are favouring well differentiated companies with good revenue visibility, strong balance sheets and capable management teams. We are underweight stocks dependent on discretionary UK consumer spending. Latest information is available by typing www.blackrock.co.uk/its on the internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV terminal). 23 February 2009
UK 100

Latest directors dealings